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4-1 , Shimookui 2-chome, Toyama 930-8508, Japan (Received for publication May 1, 2001) 2-Deoxy-D-grucose-6-phosphate ketol-isomerase (EC 2.6.1.16) forms glucosamine-6-phosphate and glutamate from fructose-6-phosphate and glutamine and plays an important role in chitin synthesis in fungi. Wehave established a new assay for fungal ketol-isomerase activity that is amenable to high throughput screening to identify enzyme inhibitors. Aspergillus fumigatus crude lysate was incubated with substrates and after incubation, reactions were terminated. Glutamate dehydrogenase, nitro blue tetrazolium chloride, phenazine methosulfate and /J-NAD were added and the amount of glutamate formed by ketol-isomerase activity was determined by measuring OD585nm. A feedback inhibitor, UDP-TV-acetylglucosamine, of fungal ketol-isomerase was successfully detected by this assay (IC5'0=0.48him).
In a pilot scale screening, an active extract from an extremophilic bacterium was found, and the extract showed antifungal activity against A. fumigatus, Candida albicans and C. glabrata.
During the last three decades, there has been a dramatic increase in the frequency of fungal infections, especially disseminated systemic mycoses in immunocompromised patients1>2).
Human pathogenic fungi of particular importance include: Candida spp. {e.g., C. albicans, C. glabrata, C. krusei and C. parapsilosis), Aspergillus fumigatus and Cryptococcus neoformans. C. albicans and A. fumigatus cause most opportunistic mycoses. At present, treatments for fungal infections are limited to few options. Amphotericin B (a polyene) shows a fungicidal effect, but is toxic to humans3). Azoles, such as fluconazole and itraconazole, are safer than amphotericin B, but are fungistatic3). In addition, resistance to azoles has becomean increasing problem in the treatment of fungal infections4). Thus, there remains a need for the development of new drugs useful for treatment of fungal infections. The most striking difference between fungal cells and humancells is that fungal cells are encased in a wall that protects them from an osmotically and immunologically hostile external environment. The cell wall of fungi has a complex composition and structure. Yeast cell walls consist pp.737 -743 of roughly equimolar amounts of (I,3)j3-glucan, (l,6)/3-glucan, mannoprotein, and submolar amounts of chitin5). Chitin, although a minor component of yeast and filamentous fungal cell walls, is essential for cell viability and mother-daughter cell separation6'7). Therefore, chitin synthase has been considered a possible target for antifungal treatment^1 ] ). Unfortunately, although polyoxins and nikkomycins inhibit chitin synthase and the growth of fungi12), none of them has proven useful as therapeutic agents.
Chitin synthases polymerize UDP-TV-acetylglucosamine (UDP-GlcNAc) to a (I,4)j8-linked polymer of Nacetylglucosamine, chitin. The precursor, UDP-GlcNAc, is
formed from fructose-6-phosphate via four sequential enzymatic reactions-the Leloir Pathway13). The first enzyme of the Leloir Pathway is 2-deoxy-D-glucose-6-phosphate ketol-isomerase (ketol-isomerase) (EC 2.6. 1. 1 6), which is variously called: glutamine: fructose-6-phosphate amidotransferase or glucosamine-6-phosphate synthase. This enzyme forms glucosamine-6-phosphate (GlcN-6-P) and glutamate from fructose-6-phosphate and glutamine14). formed by ketol-isomerase activity were calculated from the standard curve.
To test the effect of putative inhibitors, 2\i\ of each sample dissolved in DMSOwere added before addition of cell lysate. The assay was performed as described above.
Comparison between Glutamate and GlcN-6-P
Concentrations
Ketol-isomerase reactions were performed as described above except that the volume was 100^1 in microcentrifuge tubes and reactions were terminated by boiling for 5 minutes. After termination, precipitated protein was removed by centrifugation at 10,000 # for 10 minutes. The amounts of glutamate and GlcN-6-P formed by reactions were determined by the nitro BTassay and the MorganElson assay (described below), respectively.
Morgan-Elson Assay
The amounts of GlcN-6-P formed by reaction mixtures were determined by using a modification of the MorganElson assay20). Briefly, 5 /xl.of saturated NaHCO3 and 5^1 of cold 5%acetic anhydride were added to 30^1 aliquots of reaction mixtures (prepared and incubated as described above) in micro-centrifuge tubes. After incubation at room temperature for 3 minutes, tubes were boiled for 3 minutes, and then 50^1 of 0.27m sodium borate was added. The tubes were boiled for 8 minutes, and cooled to room temperature, and 400^1 of Ehrlich's reagent was added. Tubes were incubated at 37°C for 20 minutes and then the OD585nmof each sample was measured. GlcN-6-P standards in cell lysate were determined in parallel to generate a standard curve.
Protein Assays
Protein concentrations were determined by the methodof Bradford2^using BioRad protein assay reagent and BSA fraction V as a standard.
Results and Discussion
A Novel Assay to Measure Ketol-isomerase Activity Some methods to determine ketol-isomerase activity were previously reported, i.e. the Morgan-Elson assay20), a spectrophotometric assay22) and a high performance liquid chromatography (HPLC) assay23). But, none of them is suitable for high throughput screening. For example, boiling and addition of unstable reagents are needed in the Morgan-Elson assay, and measurement of ultra-violet absorption is needed in the spectrophotometric assay. Therefore, the establishment of a new ketol-isomerase assay, which is applicable for microtiter plates, would permit screening for new antifungal drugs.
The experimental design of the new ketol-isomerase assay is summarized in Fig. 1 determined by the addition of mixtures containing GLDH, /3-NAD, PMS and nitro BT (nitro BT assay).
Using the nitro BT assay, we partially characterized ketol-isomerase activity present in crude cell lysates of A. fumigatus. The formation of glutajnate by complete reactions was linear up to 60 minutes incubation at 37°C (Fig.  2) . The specific activity of the lysate was 1 5 nmol/minute/mg protein. In contrast, in control mixtures lacking Fru-6-P, glutamine or cell lysate, the formation of glutamate was less than 8%of complete mixtures. These results indicate that glutamate was formed by ketolisomerase activity, and not by other endogenous aminotransferase or deaminase activities.
In order to confirm that glutamate, detected by the nitro BT assay, wa § formed by ketol-isomerase activity, we compared the amounts of glutamate and GlcN-6-P formed by ketol-isomerase reactions using the nitro BTassay and the Morgan-Elson assay, respectively. These results are shown in Fig. 3 . Note that there were no differences between the amounts of glutamate and GlcN-6-P formed in the reaction mixtures measured by these independent assays. These results clearly show that both glutamate and GlcN-6-P were formed by ketol-isomerase activity present in A. fumigatus crude lysates, and that the activity was successfully quantitated by the nitro BTassay. In addition, the assay was little influenced by other endogenous enzymesor compoundspresent in crude lysates.
It is well known that eukaryotic ketol-isomerases are feedback-inhibited by UDP-GlcNAc15'16'25~28). Therefore, were incubated at 37°C. The amount of glutamate was determined as described in Materials and Methods.
The experiment was performed in triplicate. Each symbol represents the mean and the error bars represent the standard deviation. using the nitro BT assay, we determined the effect of UDPGlcNAc on A. fumigatus ketol-isomerase activity in crude lysates. The inhibitory effect of UDP-GlcNAcwas dosedependent and the IC50 was 0.48niM (Fig. 4) . The IC50 for A. fumigatus enzyme was comparable to those for C. albicans26) and Saccharomyces cerevisiae25^enzymes, but, was muchhigher than those for mouse, rat and humanliver enzymes27s28).
To date, ketol-isomerase activity has been partially characterized from some fungi and yeasts14~18?25), but not from A. fumigatus. In preliminary studies, we determined that the highest specific activity of A. fumigatus ketolisomerase was found using KI buffer. The activity in KI buffer was not degraded after freeze-thaw, and was stable at -80°C for at least 4 weeks (data not shown). These findings and the new assay will enable large scale screening for A. fumigatus ketol-isomerase inhibitors.
7V-Acetylglucosamine is an important constituent not only for fungal cell wall chitin but also for bacterial cell wall peptidoglycan. A. fumigatus ketol-isomerase activity.
UDP-GlcNAc (mM)
The indicated amounts of UDP-GlcNAc were incubated with lOmM fructose-6-phosphate, 10mM glutamine and 0.3 mg/ml A. fumigatus cell lysate at 37°C for 60 minutes. The amount of glutamate formed by each mixture was determined as described in Materials and Methods. The experiment was performed in triplicate. Each bar represents the mean and the error bars represent the standard deviation. a Sampleswere extracted from the spent mediumof extremophilic bacteria with ethyl acetate, dried and resuspended in DMSO29).Extracts were tested for inhibition of fungal cell growth and A. fumigatus ketol-isomerase activity. b Antifungal activity was initially determined using an agar diffusion method. The activity of positives was confirmed by a microbroth dilution method. The samples that inhibited growth at = 1000 jig/mL were judged as positive (+). c C. albicans and C. glabrata d (+) indicates >50%inhibition ofenzyme activity using the nitro BT assay at 800 ug/mL; (-) indicates no significant inhibition.
extracts, prepared by grinding with alumina, was 19 nmol/minute/mg, similar to that found for A. fumigatus. Wesuggest that bacterial ketol-isomerase activity in crude bacterial lysates may be determined using the nitro BT assay, i.e., the nitro BT assay may be applicable to screen for both fungal and bacterial ketol-isomerase inhibitors using crude cell lysates from each organism.
A Pilot Scale Screening for A. fumigatus Ketol-isomerase Inhibitors A major difficulty with in vitro enzyme screening is that the numberof samples that test positive is often in excess of 5%, indicating that the screening is not selective enough to be useful. all tested organisms (IC50: 1000//g/ml for C. albicans, 500/J,g/m\ for C. glabrata, 62.5^g/ml for A. fumigatus, IC90: 1000fig/ml for C. albicans and C. glabmta, 500//g/ml for A. fumigatus,). In contrast, the inhibitory effect on ketol-isomerase activity was 76%at 400iag/ml and 30% at 100 /Lig/ml (data not shown).
Screening natural products using fungal whole cell assays to identify antifungal compounds often selects compoundsthat have no specificity to fungi. Using the in vitro ketol-isomerase assay, we found less than 1 % positives in the pilot scale screening. Importantly, the positive sample showed antifungal activity. Although the number of positives detected by the nitro BTassay were muchless than that detected by the whole-cell assays, the enzyme assay will be more efficient for screening for selective antifungal drugs compared to whole-cell assays.
Partial Purification of a Ketol-isomerase Inhibitor Based on the results described above, we chose the extract from MB365as a subject for further studies. The sample was separated into 72 fractions by reverse phase high performance liquid chromatography using methodology to be described elsewhere (O'Rourke, et al, in preparation). The effect of each fraction on A. fumigatus ketol-isomerase activity was determined using the nitro BT assay. In addition, antifungal activity of each fraction against C. glabrata ATCC 48435 was also determined FractionNo.
The extract of MB365was fractionated by reverse phase HPLC. Each fraction was dried and dissolved in DMSO. The effect on A. fumigatus ketol-isomerase was determined by the nitro BT assay as described in Materials and Methods. The antifungal activity was determined by an agar diffusion method using C. glabrata as a test organism. The arrows indicate fractions active against C. glabrata (inhibitory zone diameter;^1 0 mm).
using an agar diffusion method. These results are shownin Fig. 5 . There were four peaks that inhibited the enzyme activity. The first active peak corresponds to fraction 6, and the second and the third peaks correspond to fractions 27-28 and 46-47, respectively.
The inhibitory effect in the fourth peak (fraction 62) was slightly lower than that in the other three peaks. Interestingly, antifungal activity was found only in the third peak (fractions 46-47).
To investigate the reason whyfractions 6, 27, and 28 had no antifungal activity but resulted in a decrease in OD585nm, wetested the effects of the fractions on ketol-isomerase activity using the Morgan-Elson assay. Although inhibition was found in fractions 6, 27, and 28 by the nitro BT assay, these fractions showed no effect on the formation of GlcNAc-6-P as determined by the Morgan-Elson assay (data not shown). In the nitro BT assay, an exogenous enzyme, GLDH, needs to be added. Therefore, GLDH inhibitors as well as ketol-isomerase inhibitors could be detected using the nitro BT assay. To confirm this hypothesis, we tested the inhibitory effect of each fraction on GLDHactivity by using a modification of the nitro BT assay. The procedure was identical to the nitro BTassay (described in Materials and Methods) except that glutamate dissolved in KI buffer was added instead of crude lysate and substrates. Fractions 6, 27, and 28 inhibited GLDH activity and the inhibitory effects were comparable to those determined by the nitro BTassay (data not shown). Taken together, we conclude that these three fractions have no inhibitory effect on ketol-isomerase activity but inhibited GLDHactivity. In contrast, fractions 46 and 47 had no effects on GLDH activity (data not shown). It is clear that these two fractions inhibited A. fumigatus ketol-isomerase activity but not the assay to detect the formation of glutamate. NMRand MS analyses to determine the identity of the active compound are in progress. The structural elucidation and the biological activity will be the subjects of a subsequent manuscript.
Conclusion
Wehave established a new assay for ketol-isomerase activity using A. fumigatus crude lysate. The assay is specific and can be used easily for high throughput screening for new antifungal drugs. Wetested 386 extracts of extremophiles as a pilot scale screening and found an active extract. The extract also inhibited fungal cell growth. This assay will lead to the isolation of entirely new classes of antifungal drugs with a novel mechanism of action. In addition, this assay will be also applicable for screening for newantibacterial drugs.
